Literature DB >> 7742441

Human immunodeficiency virus infection and porphyria cutanea tarda: coexistence of risk factors or causative association?

F McAlister1, K McClean, P G Hamilton, S Houston.   

Abstract

Several recent reports have described an association between human immunodeficiency virus (HIV) infection and porphyria cutanea tarda (PCT). We describe two HIV-infected patients who developed PCT and review 29 other reported cases of coexistent PCT and infection due to HIV. Recognized porphyrinogenic factors were identified in our patients and in 27 of the 29 cases described in the literature. Even in the two cases that lacked obvious precipitant factors for PCT, the possibility of hepatitis C was not excluded. This fact suggests that the co-occurrence of PCT and infection due to HIV may reflect the coexistence of risk factors for the two diseases rather than a causal association. Despite concern that exposure to sulfonamides might exacerbate porphyria, one of our patients and three patients described in the literature were safely treated with sulfonamides.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7742441     DOI: 10.1093/clinids/20.2.348

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  5 in total

Review 1.  Porphyria Diagnostics-Part 1: A Brief Overview of the Porphyrias.

Authors:  Vaithamanithi-Mudumbai Sadagopa Ramanujam; Karl Elmo Anderson
Journal:  Curr Protoc Hum Genet       Date:  2015-07-01

2.  Highly active antiretroviral therapy leading to resolution of porphyria cutanea tarda in a patient with AIDS and hepatitis C.

Authors:  J D Rich; E Mylonakis; R Nossa; R M Chapnick
Journal:  Dig Dis Sci       Date:  1999-05       Impact factor: 3.199

3.  Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency.

Authors:  Norman G Egger; Douglas E Goeger; Deborah A Payne; Emil P Miskovsky; Steven A Weinman; Karl E Anderson
Journal:  Dig Dis Sci       Date:  2002-02       Impact factor: 3.199

4.  Porphyria cutanea tarda in a human immunodeficiency virus-infected patient: A rare scenario in India.

Authors:  Ramesh M Bhat; Malcolm Pinto; S Dandakeri; Srinath M Kambil
Journal:  Indian J Sex Transm Dis AIDS       Date:  2014-01

5.  Precipitating factors of porphyria cutanea tarda in Brazil with emphasis on hemochromatosis gene (HFE) mutations. Study of 60 patients.

Authors:  Fatima Mendonça Jorge Vieira; Maria Cristina Nakhle; Clarice Pires Abrantes-Lemos; Eduardo Luiz Rachid Cançado; Vitor Manoel Silva dos Reis
Journal:  An Bras Dermatol       Date:  2013 Jul-Aug       Impact factor: 1.896

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.